davelizomib   Click here for help

GtoPdb Ligand ID: 12887

Compound class: Synthetic organic
Comment: The structure for davelizomib was obtained from proposed INN list 129 (August 2023) where it is described as a proteasome inhibitor and antineoplastic agent. It is example I-1 in patent JP2021531302A. This patent encompasses use of claimed compounds for the treatment of multiple myeloma, and identifies its potential in MM that is resistant to treatment with the existing proteasome inhibitor bortezomib.
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 10
Hydrogen bond donors 3
Rotatable bonds 12
Topological polar surface area 134.27
Molecular weight 481.26
XLogP 1.52
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC(C)C[C@@H](B1O[C@@H](CC(=O)O)C(=O)O1)NC(=O)CNC(=O)[C@@H]2CCN2C3=CC=C(C=C3F)F
Isomeric SMILES B1(O[C@H](C(=O)O1)CC(=O)O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H]2CCN2C3=C(C=C(C=C3)F)F
InChI InChI=1S/C21H26BF2N3O7/c1-11(2)7-17(22-33-16(9-19(29)30)21(32)34-22)26-18(28)10-25-20(31)15-5-6-27(15)14-4-3-12(23)8-13(14)24/h3-4,8,11,15-17H,5-7,9-10H2,1-2H3,(H,25,31)(H,26,28)(H,29,30)/t15-,16-,17-/m0/s1
InChI Key BMSAGHWUHGTMIV-ULQDDVLXSA-N
Classification Click here for help
Compound class Synthetic organic
IUPAC Name Click here for help
2-[(4S)-2-[(1R)-1-[[2-[[(2S)-1-(2,4-difluorophenyl)azetidine-2-carbonyl]amino]acetyl]amino]-3-methylbutyl]-5-oxo-1,3,2-dioxaborolan-4-yl]acetic acid
Database Links Click here for help
CAS Registry No. 2409841-51-4 (source: WHO INN record)
GtoPdb PubChem SID 485206008
PubChem CID 147112102
Search Google for chemical match using the InChIKey BMSAGHWUHGTMIV-ULQDDVLXSA-N
Search Google for chemicals with the same backbone BMSAGHWUHGTMIV
UniChem Compound Search for chemical match using the InChIKey BMSAGHWUHGTMIV-ULQDDVLXSA-N
UniChem Connectivity Search for chemical match using the InChIKey BMSAGHWUHGTMIV-ULQDDVLXSA-N